PHRRF (PharmaTher Holdings) Additional Paid-In Capital : $0.38 Mil(As of Feb. 2025)

View and export this data going back to 2020. Start your Free Trial

What is PharmaTher Holdings Additional Paid-In Capital?

PharmaTher Holdings's quarterly additional paid-in capital declined from Aug. 2024 ($0.40 Mil) to Nov. 2024 ($0.39 Mil) but then stayed the same from Nov. 2024 ($0.39 Mil) to Feb. 2025 ($0.38 Mil).

PharmaTher Holdings's annual additional paid-in capital increased from May. 2021 ($0.28 Mil) to May. 2022 ($0.50 Mil) but then declined from May. 2022 ($0.50 Mil) to May. 2023 ($0.48 Mil).

PharmaTher Holdings Additional Paid-In Capital Historical Data

The historical data trend for PharmaTher Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Additional Paid-In Capital Chart

PharmaTher Holdings Annual Data

Trend

May21

May22

May23

Additional Paid-In Capital

0.28

0.50

0.48

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	Aug24	Nov24	Feb25
Additional Paid-In Capital	Get a 7-Day Free Trial													0.47	0.43	0.40	0.39	0.38

PharmaTher Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

PharmaTher Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (OTCPK:PHRRF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

PHRM:Canada

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmather.com

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.